Refine by
Glaucoma Patient Suppliers Serving Libya
5 companies found
based inWetzlar, GERMANY
OCULUS has been a trusted partner for eye care professionals around the world. With the highest attention to detail, our devices are designed and manufactured at the OCULUS headquarters, located in Wetzlar, Germany. Thanks to our 11 subsidiaries in ...
The OCULUS Easyfield is designed for use as a visual field screener and a threshold perimeter for immediate re-examination of any abnormal findings. Full compliance with Goldman Standards makes the Easyfield ideal for all common examinations of the ...
based inMinneapolis, MINNESOTA (USA)
Since 1985, we've made it our mission to help address the treatment needs and transform the sight of people across the globe. From the introduction of the first Ellex ophthalmic laser in 1987, through to our partnership with some of the world's ...
Selective Laser Trabeculoplasty (SLT) is clinically proven by the LiGHT trial to be a safe and effective first-line therapy for the treatment of primary open angle glaucoma or ocular ...
based inVancouver, BRITISH COLUMBIA (CANADA)
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet ...
based inDepew, NEW YORK (USA)
Reichert Technologies, based in Buffalo, New York, is a global leader in designing, engineering, and manufacturing high-quality diagnostic devices and equipment for ophthalmologists, optometrists, opticians, and retail eye centers. Inventor of ...
A New, Modern, Patented Prism Designed for Your Goldmann Tonometer. CATS® Tonometer Prism features a unique, patented, dual-curved surface design that successfully reduces measurement errors caused by corneal biomechanics, corneal thickness, and ...
based inWavre, BELGIUM
iSTAR Medical SA, founded in 2011 and headquartered in Wavre, Belgium, is a clinical-stage, medical technology company focused on the development of novel ophthalmic implants for patients with glaucoma. Glaucoma is the second leading cause of adult ...